Re-Expression of AKAP12 inhibits progression and metastasis potential of colorectal carcinoma in vivo and in vitro

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Liu, Weiwei ^a   Guan, Ming ^a   Hu, Tingting ^a   Gu, Xiaoye ^a   Lu, Yuan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 12; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; AKAP12 PROTEIN, HUMAN; CELL CYCLE PROTEIN;

AKAP12 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CARCINOMA; GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; COLORECTAL TUMOR; DISEASE COURSE; DRUG SCREENING; FEMALE; FLOW CYTOMETRY; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

MUS; MUS MUSCULUS;

A KINASE ANCHOR PROTEINS; ANIMALS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80052297380     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024015     Document Type: Article

References (28)

1. Wallner M, Herbst A, Behrens A, Crispin A, Stieber P, et al. (2006) Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Clin Cancer Res 12: 7347-7352.
2. Agrawal A, Murphy RF, Agrawal DK, (2007) DNA methylation in breast and colorectal cancers. Mod Pathol 20: 711-721.
3. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2007) Cancer statistics 2007. CA Cancer J Clin 57: 43-66.
4. Gordon T, Grove B, Loftus JC, O'Toole T, McMillan R, et al. (1992) Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera. J Clin Invest 90: 992-999.
5. Nauert JB, Klauck TM, Langeberg LK, Scott JD, (1997) Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein. Curr Biol 7: 52-62.
6. Tessema M, Willink R, Do K, Yu YY, Yu W, et al. (2008) Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25. Cancer Res 68: 1707-1714.
7. Wang HY, Tao J, Shumay E, Malbon CC, (2006) G-Protein-coupled receptor-associated A-kinase anchoring proteins: AKAP79 and AKAP250 (gravin). Eur J Cell Biol 85: 643-650.
8. Choi MC, Jong HS, Kim TY, Song SH, Lee DS, et al. (2004) AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene 23: 7095-7103.
9. Jin Z, Hamilton JP, Yang J, Mori Y, Olaru A, et al. (2008) Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression. Cancer Epidemiol Biomarkers Prev 17: 111-117.
10. Flotho C, Paulun A, Batz C, Niemeyer CM, (2007) AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies. Br J Haematol 138: 644-650.
11. Heller G, Schmidt WM, Ziegler B, Holzer S, Mullauer L, et al. (2008) Genome-wide transcriptional response to 5-aza-2′-deoxycytidine and trichostatin a in multiple myeloma cells. Cancer Res 68: 44-54.
12. Mori Y, Cai K, Cheng Y, Wang S, Paun B, et al. (2006) A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. Gastroenterology 131: 797-808.
13. Liu W, Guan M, Su B, Ye C, Li J, et al. (2010) Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with dukes' stage. Cancer Biol Ther 9: 862-871.
14. Lowe SW, Lin AW, (2000) Apoptosis in cancer. Carcinogenesis 21: 485-495.
15. Lin X, Nelson P, Gelman IH, (2000) SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D. Mol Cell Biol 20: 7259-7272.
16. Lin X, Gelman IH, (1997) Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis. Cancer Res 57: 2304-2312.
17. Xia W, Unger P, Miller L, Nelson J, Gelman IH, (2001) The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res 61: 5644-5651.
18. Yoon DK, Jeong CH, Jun HO, Chun KH, Cha JH, et al. (2007) AKAP12 induces apoptotic cell death in human fibrosarcoma cells by regulating CDKI-cyclin D1 and caspase-3 activity. Cancer Lett 254: 111-118.
19. Liu Y, Gao L, Gelman IH, (2006) SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis. BMC Cancer 6: 105.
20. Frisch SM, Francis H, (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619-626.
21. Liotta LA, Kohn E, (2004) Anoikis: cancer and the homeless cell. Nature 430: 973-974.
22. Li HZ, Gao Y, Zhao XL, Liu YX, Sun BC, et al. (2009) Effects of Raf Kinase Inhibitor Protein Expression on Metastasis and Progression of Human Breast Cancer. Mol Cancer Res 7: 832-840.
23. Su B, Zheng Q, Vaughan MM, Bu Y, Gelman IH, (2006) SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition. Cancer Res 66: 5599-5607.
24. Su B, Bu Y, Engelberg D, Gelman IH, (2009) SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a PKC-RAF/MEK/ERK pathway. J Biol Chem 285: 4578-4586.
25. Weiser DC, Pyati UJ, Kimelman D, (2007) Gravin regulates mesodermal cell behavior changes required for axis elongation during zebrafish gastrulation. Genes Dev 21: 1559-1571.
26. Guan M, Yam HF, Su B, Chan KP, Pang CP, et al. (2003) Loss of pigment epithelium derived factor expression in glioma progression. J Clin Pathol 56: 277-282.
27. Li J, Huang H, Sun L, Yang M, Pan C, et al. (2009) MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 15: 3998-4008.
28. Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH, (2008) Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Toxicol Appl Pharmacol 226: 178-191.